Drug
J022x ST
J022x ST: highest development phase Phase 3, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| J022X ST NCT01948856 | Phase 3 | Recurrent Upper-Respiratory Tract Infections |
Latest
No recent events.
Follow J022x ST on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.